Literature DB >> 3786604

Interface of panic and depression: clinical and sleep EEG correlates.

S Dubé, D A Jones, J Bell, A Davies, E Ross, N Sitaram.   

Abstract

Four groups of subjects were compared with respect to their clinical and demographic status and electroencephalographic (EEG) characteristics, namely: primary major depressive disorder (PRI MDD); panic disorder (Panic); "Mixed" group comprising patients meeting full syndromal criteria for MDD and panic occurring concomitantly; and normal controls. The "Mixed" (MDD + Panic) patients were characterized by earlier age of onset of psychiatric illness, longer duration of current episode, greater intensity of symptoms, higher impairment of functioning, increased miscellaneous psychopathology, and greater objective stress and anger. With respect to sleep EEG variables, PRI MDD patients were clearly different from the other three groups. The sleep profile of the "Mixed" group occupies an intermediate position between the "pure" Panic and MDD groups. Classification of the "Mixed" patients based on the discriminant function coefficients of the Schedule for Affective Disorders and Schizophrenia and sleep analysis of the "pure" groups (PRI MDD and Panic) reveals that some patients are classified as true PRI MDD while others are classified as falling somewhere along the PRI-MDD/Panic spectrum. The separation of the PRI MDD from Panic and Normals, however, is clear, suggesting that sleep can be successfully used as a physiological marker in the separation of these conditions.

Entities:  

Mesh:

Year:  1986        PMID: 3786604     DOI: 10.1016/0165-1781(86)90005-3

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

Review 1.  Using family studies to understand comorbidity.

Authors:  P J Wickramaratne; M M Weissman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 2.  Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms.

Authors:  Anne Richards; Jennifer C Kanady; Thomas C Neylan
Journal:  Neuropsychopharmacology       Date:  2019-08-23       Impact factor: 7.853

3.  Sleep and anxiety disorders.

Authors:  Luc Staner
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.